Control of meningococcal infection in the African meningitis belt by selective vaccination.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  The Lancet

• Publication date

  1980-04-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(80)91230-1PMID 6103155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The duration of the antibody response to meningococcal vaccination in an African village.

  1980cited by this paper
• Prevention of secondary cases of meningococcal disease in household contacts by vaccination.

  1978cited by this paper
• Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland.

  1978cited by this paper
• Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization.

  1977cited by this paper
• Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.

  1977cited by this paper
• A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.

  1977cited by this paper
• Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide.

  1975cited by this paper
• A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.

  1973cited by this paper
• A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.

  1973cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper

• Alternative vaccine delivery methods

  2020cites this paper
• Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad

  2017cites this paper
• Fighting Neisseria meningitidis: past and current vaccination strategies

  2016cites this paper
• The genus Neisseria

  2014cites this paper
• Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis

  2012cites this paper
• Cochrane Review: Polysaccharide vaccines for preventing serogroup A meningococcal meningitis

  2011cites this paper
• Meningococcal a and Other Polysaccharide Vaccines

  2010cites this paper
• The temporal and geographical distribution and diversity of disease-associated Neisseria meningitidis genetic types in Europe

  2010influential citation
• Loss of sulfonamide resistance in Neisseria meningitidis.

  2009cites this paper
• Meningococcal meningitis in Mali: a long-term study of persistence and spread.

  2009cites this paper
• Meningococcal disease in international travel: vaccine strategies.

  2008cites this paper
• Control of meningococcal meningitis outbreaks in sub-Saharan Africa.

  2008influential citation
• An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.

  2007cites this paper
• Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae and Streptococcus sp. by polymerase chain reaction for the diagnosis of bacterial meningitis.

  2005cites this paper
• Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.

  2005cites this paper
• Meningococcal conjugate vaccines

  2004cites this paper
• Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.

  2003cites this paper
• Development of vaccines against meningococcal disease.

  2002cites this paper
• [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].

  2002cites this paper
• A Critical Review of Control Strategies against Meningococcal Meningitis Epidemics in Sub-Saharan African Countries

  2002influential citation
• A predictable coheback : the second pandemic of infections caused by Neisseria meningritidis serogroup A subgroup 111 in Africa , 1995

  2002cites this paper
• Meningococcal vaccines and vaccine developments.

  2001cites this paper
• Prospects offered by genome studies for combating meningococcal disease by vaccination.

  2001cites this paper
• Development of natural immunity to Neisseria meningitidis.

  2001cites this paper
• A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.

  2000cites this paper
• Vaccines for prevention of meningococcal disease

  2000cites this paper
• Emergency or routine vaccination against meningococcal disease in Africa?

  2000cites this paper
• A severe epidemic of meningococcal meningitis in Nigeria, 1996.

  2000cites this paper
• Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library.

  2000cites this paper
• A cost-effectiveness analysis of vaccination strategies against N. meningitidis meningitis in sub-Saharan African countries.

  1999cites this paper
• Human Immune Response to a Peptide Mimic of Neisseria meningitidis Serogroup C in hu-PBMC-SCID Mice

  1999cites this paper
• Manson Lecture. Meningococcal meningitis in Africa.

  1999cites this paper
• Meningococcal Vaccines

  1998cites this paper
• Clinical predictors of epidemic outcome in meningococcal infection in Jos, Nigeria.

  1997cites this paper
• Community immunization programme in response to an outbreak of invasive Neisseria meningitidis serogroup C infection in the Trent region of England 1995-1996.

  1997cites this paper
• Meningococcal meningitis reported to WHO in sub-Saharan Africa "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

  1997cites this paper
• "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.

  1997cites this paper
• A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995.

  1996cites this paper
• An ELISA assay for the rapid diagnosis of acute bacterial meningitis.

  1995cites this paper
• The worldwide prevention of meningococcal infection. Still an elusive goal.

  1995cites this paper
• A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

  1995cites this paper
• Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic

  1995cites this paper
• Responses to tuberculin and meningococcal polysaccharide vaccination during ageing in Nigerians.

  1995cites this paper
• Pattern and antibiotic susceptibility of bacteria in pyogenic meningitis in a children's emergency room population in Maiduguri, Nigeria, 1988–1992

  1994cites this paper
• [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].

  1993cites this paper
• Meningococcal vaccines.

  1993cites this paper
• Detection of meningitis epidemics in Africa: a population-based analysis.

  1992cites this paper
• Vaccines

  1991cites this paper
• Vaccines Against Bacterial Infections of Children

  1991cites this paper
• T MENINGITIS IN THE SUDAN: An epidemiological, clinical and laboratory study

  1990cites this paper
• Clinical features and complications of epidemic group A meningococcal disease in Sudanese children.

  1990cites this paper
• Features of a large epidemic of group A meningococcal meningitis in Khartoum, Sudan in 1988.

  1990cites this paper
• Vaccine-preventable disease and immunization in the developing world.

  1990cites this paper
• Surveillance and control of meningococcal meningitis epidemics in refugee populations.

  1990cites this paper
• Childhood acute bacterial meningitis in the Sudan: an epidemiological, clinical and laboratory study.

  1989cites this paper
• Rapid diagnosis of bacterial meningitis by an enzyme immunoassay of cerebrospinal fluid

  1989cites this paper
• Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.

  1988cites this paper
• Meningococcal diseases in the 1980s: epidemiology, prevention and control

  1988cites this paper
• Spectrum of disease due to Haemophilus influenzae type b occurring in vaccinated children.

  1988cites this paper
• Control of epidemic group A meningococcal meningitis in Nepal.

  1987cites this paper
• Control of meningococcal epidemics

  1987cites this paper
• Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa.

  1987cites this paper
• Vaccines against encapsulated bacteria: a global agenda.

  1987cites this paper
• Prospects for the prevention of meningococcal disease: special reference to group B.

  1987cites this paper
• Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak

  1986cites this paper
• Splenectomy--a long-term risk of infection.

  1985cites this paper
• Defences against meningococcal infections.

  1985cites this paper
• Neisseria meningitidis

  1985cites this paper
• Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.

  1984cites this paper
• Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.

  1984cites this paper
• Meningococcal disease and season in sub-Saharan Africa.

  1984cites this paper
• Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program.

  1984cites this paper
• Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.

  1984cites this paper
• Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.

  1983cites this paper
• Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.

  1983cites this paper
• Epidemic group C meningococcal meningitis in Upper Volta, 1979.

  1983cites this paper
• Epidemic meningococcal meningitis: the case of Mali.

  1983cites this paper
• Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys.

  1983cites this paper
• A bacteriological study of cerebrospinal fluids for pyogenic meningitis in Kenyatta National Hospital, Nairobi.

  1983cites this paper
• The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria.

  1982cites this paper
• Epidemic meningococcal disease in an elementary-school classroom.

  1982cites this paper
• [Vaccination: 1982 status].

  1982cites this paper
• Schutzimpfungen: Stand 1982

  1982cites this paper
• Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.

  1982cites this paper
• Control of epidemic meningococcal meningitis by mass vaccination.

  1981cites this paper
• [Recurrent meningococcal meningitis associated with complement C6 deficiency (author's transl)].

  1981cites this paper
• Vaccination today.

  1980cites this paper